Skip to main content

Epidermal Radionuclide Therapy: Dermatological High-Dose-Rate Brachytherapy for the Treatment of Basal and Squamous Cell Carcinoma

  • Chapter
  • First Online:

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

Abstract

Non-melanocytic skin cancer (NMSC) is the most frequent malignancy among populations of European origin, and in some countries it accounts for about half of all tumours. In the present paper a therapeutic option for the treatment of Basal CellCell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC) is described. It basically consists in a superficial high dose brachytherapy, characterised by the use of radioactive beta emitting isotopes, incorporated in a specially formulated inert, synthetic resin, which is applied on the surface of skin tumours. The electrons from high energy (> 1MeV) beta emitters isotopes deposit more than 90 % of the dose to the first 2 mm of the skin, which is the depth usually interested from tumour invasion, but spare the deeper tissues from irradiation. The therapy has been used in a large variety of BCC and SCC: tumours of very large sizes, relapsing or recurrent forms, multifocal lesions, without restriction of site, dimension, clinical or histological type, patients clinical situation. A complete response was obtained in 95% of the treated lesions, and in 84 % of the lesions after a single application. A clear advantage of the proposed nuclear medicine therapeutic treatment with respect to the surgery is especially evident for all the tumours located in difficult sites, on which surgery would be difficult (nose, ears) or would produce functional mutilations (penis, vulva, eyelids)

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • American Cancer Society (2008) Cancer facts and figures. ACS, Atlanta. http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf

  • Astner S, Dietterle S, Otberg N, Röwert-Huber HJ, Stockfleth E, Lademann J (2008) Clinical applicability of in vivo fluorescence confocal microscopy for noninvasive diagnosis and therapeutic monitoring of nonmelanoma skin cancer. J Biomed Opt 13(1):014003

    Google Scholar 

  • Beauleu Lacoste I, Joly P, Ruto F, Thomine F, Fusade T, Chevaillier B, Ortoli JC, Lauret P (1993) Metastatic basal cell carcinoma. Ann Dermatol Venerol 120(2):135–138

    Google Scholar 

  • Bianchi L, Orlandi A, Campione E (2004) Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases. Br J Dermatol 151:148–56

    Google Scholar 

  • Cassarino DS, Derienzo PD, Barr RJ (2006) Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification-part II. J Cutan Pathol 33(4):261–279

    Google Scholar 

  • Chan S, Dhadda AS, Swindell R (2007) Single fraction radiotherapy for small superficial carcinoma of the skin, Clin Oncol (R Coll Radiol) 19(4):256–259

    Google Scholar 

  • Cornell RC, Greenway HT, Tucker SB et al (1992) Intralesional interferon therapy for basal cell carcinoma. J Am Acad Dermatol 26:117–120

    Google Scholar 

  • Fleming I, Amonette MD, Managhan T, Fleming I (1995) Principles of management of basal and squamous cell carcinoma of the skin. Cancer 75 (suppl no 2):699–704

    Google Scholar 

  • Gallagher RP, Hill GB, Bajdik CD et al (1995) Sunlight exposure, pigmentary factors, and risk of non melanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 131:157–163

    Google Scholar 

  • Garcia L, Nagore E, Llombart B, Sanmartin O, Botella-Estrada R, Requena C, Jorda E, Guillen C (2006) Basal cell carcinoma of the nasolabial fold: an apparently ‘benign’ tumour that often needs complex surgery. J Eur Acad Dermatol Venereol 20(8):926–930

    Article  CAS  PubMed  Google Scholar 

  • Garnett CT, Palena C, Chakraborty M, Tsang KY, Schlom J, Hodge JW (2004) Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes. Cancer Res 64(21):7985–7994

    Article  CAS  PubMed  Google Scholar 

  • Geisse J, Caro I, Lindholm J (2004) Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle controlled studies. J Am Acad Dermatol 50:722–733

    Google Scholar 

  • Goldberg LH (1996) Basal cell carcinoma. Lancet 347:663–667

    Article  CAS  PubMed  Google Scholar 

  • Guo HR, Yu HS, Hu H, Monson RR (2001) Arsenic in drinking water and skin cancers: Cell type specificity (Taiwan, ROC). Cancer Causes Control 12:909–916

    Article  CAS  PubMed  Google Scholar 

  • Jemec JB, Holm EA (2003) Non-melanoma skin cancer in organ transplant patients. Transplantation 75:253–257

    Article  PubMed  Google Scholar 

  • Lawrence N, Cottel WI (1994) Squamous cell carcinoma of skin with perineural invasion. J Am Acad Dermatol 31(1):30–33

    Article  CAS  PubMed  Google Scholar 

  • Lee K, McKean ME, McGregor IA (1985) Metastatic patterns of squamous carcinoma in the parotid lymph nodes. Br J Plast Surg 38(1):6–10

    Article  CAS  PubMed  Google Scholar 

  • Lichter MD, Karagas MR, Mott LA, Spencer SK, et al (2000) Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. Arch Dermatol 136:1007–1011

    Google Scholar 

  • Margoob AA (1997) Basal and squamous cell carcinomas: what every primary care physician should know. Postgrad Med 102:139–159

    Google Scholar 

  • Martinez JC, Otley CC (2001) The management of melanoma and non-melanoma skin cancer: a review for the primary care physician. Mayo Clinic Proc 76(1253):63

    Google Scholar 

  • Nijsten TE, Stern RS (2003) The increased risk of skin cancer is persistent after discontinuation of psoralen + ultraviolet A: a cohort study. J Invest Dermatol 121:252–258

    Article  CAS  PubMed  Google Scholar 

  • Oseroff AR, Blumenson LR, Wilson BD, Mang TS, Bellnier DA, Parsons JC, Frawley N, Cooper M, Zeitouni N, Dougherty TJ (2006) A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin) for treatment of basal cell carcinoma. Lasers Surg Med 38(5):417–426

    Google Scholar 

  • Peng Q, Warloe T, Berg K et al (1997) %-Aminolevulinic acid-based photodynamic theraphy: clinical research and future challenges. Cancer 79:2282–2308

    Google Scholar 

  • Peris K, Campione E, Micantonio T (2005) Imiquimod treatment of superficial and nodular basal cell carcinoma: 12 week open label trial. Dermatol Surg 31:318–323

    Google Scholar 

  • Petrovic D, Visnjic M, Mihailovich D, Petrovic S, Pesic Z (2004) Margin size in basocellular skin carcinoma resection: impact on relapse. Acta Fac Med Naiss 21(4):195–200

    Google Scholar 

  • Postelthwaith KR, Courteney DJ, Gosney JR (1993) Basal cell carcinoma with hepatic metastases. J Oral Maxillofac Surg 50:670–673

    Google Scholar 

  • Sauermann K, Gambichler T, Wilmert M, Rotterdam S, Stücker M, Altmeyer P, Hoffmann K (2002) Investigation of basal cell carcionoma by confocal laser scanning microscopy in vivo. Skin Res Technol 8(3):141–147

    Google Scholar 

  • Sedda AF, Rossi G, Cipriani C (2003) Beta emitter multilayer for the dermatological brachytherapy of cutaneous tumours. European Association of Nuclear Medicine—Annual congress, Amsterdam

    Google Scholar 

  • Sedda AF, Rossi G, Cipriani C, Carrozzo AM, Donati P (2007) Dermatological beta brachytherapy of basal and squamous cell carcinoma. 21st world congress of dermatology, Buenos Aires, 30 Sept–5 Oct

    Google Scholar 

  • Sedda AF, Rossi G, Cipriani C, Carrozzo AM, Donati P (2008) Dermatological high-dose-rate brachytherapy for the treatment of basal and squamous cell carcinoma. Clin Exp Dermatol 33(6):745–749

    Article  CAS  PubMed  Google Scholar 

  • Shimm DS, Wilder RB (1991) Radiation therapy for squamous cell carcinoma of the skin. Am J Clin Oncol 14:383–386

    Article  CAS  PubMed  Google Scholar 

  • Tran H, Chen K, Shumack S (2003) Epidemiology and aetiology of basal cell carcinoma, Br J Dermatol 149(Suppl 66):50–52

    Google Scholar 

  • Tavin E, Persy MS, Jacobs J (1995) Metastatic basal cell carcinoma of the head and neck. Laryngoscope 105(8PH1):814–817

    Google Scholar 

  • Triesscheijn M, Ruevekamp M, Antonini N, Neering H, Stewart FA, Baas P (2006) Optimizing meso-tetra-hydroxyphenyl-chlorin mediated photodynamic therapy for basal cell carcinoma. Photochem Photobiol 6:1686–1690

    Google Scholar 

  • Vun Y, Siller G (2006) Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study. Australas J Dermatol 47(3):169–171

    Article  PubMed  Google Scholar 

  • Wilder RB, Kittelson JM, Shimm DS (1991) Basal cell carcinoma treated with radiation therapy. Cancer 68:2134–2137

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antioco F. Sedda .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Cipriani, C., Sedda, A.F. (2012). Epidermal Radionuclide Therapy: Dermatological High-Dose-Rate Brachytherapy for the Treatment of Basal and Squamous Cell Carcinoma. In: Baum, R. (eds) Therapeutic Nuclear Medicine. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2012_778

Download citation

  • DOI: https://doi.org/10.1007/174_2012_778

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-36718-5

  • Online ISBN: 978-3-540-36719-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics